Rosa Lacerda
University of Porto
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rosa Lacerda.
Immunology Letters | 1994
Maria de Sousa; Raquel Reimão; Rosa Lacerda; Patrice Hugo; Stefan H. E. Kaufmann; Graça Porto
Abstract The present paper describes the results of a comparative histological and quantitative analysis of iron distribution in tissues of β2m−/− and β2m+/− mice of different ages. Progressive hepatic iron overload, indistinguishable from that observed in human hemochromatosis, was found only in mice homozygous for the mutated β2m gene. Total iron measurements done by flame atomic absorption showed statistically significant differences between liver samples from 5 β2m+/− heterozygotes (468 ± 174 μg/g of dry weight) and 9 mice homozygous for the mutated β2m gene with average total hepatic iron levels of 1583 ± 424 μg/g of dry weight.
BMC Medical Genetics | 2006
Eugénia Cruz; Jorge Vieira; Susana Almeida; Rosa Lacerda; Andrea Gartner; Carla Cardoso; Helena Alves; Graça Porto
BackgroundIt has been recently demonstrated that CD8+ T-lymphocyte numbers are genetically transmitted in association with the MHC class I region. The present study was designed with the objective of narrowing the region associated with the setting of CD8+ T-lymphocyte numbers in a population of C282Y homozygous hemochromatosis subjects, in whom a high prevalence of abnormally low CD8+ T-lymphocyte counts has been described.MethodsThe study includes 43 C282Y homozygous subjects fully characterized both phenotypically and genotypically. Clinical characterization includes measurements of iron parameters at diagnosis (transferrin saturation and serum ferritin), total body iron stores and T-cell immunophenotyping determined by flow cytometry. Genetic characterization includes HLA class I alleles (A, B and C) and four additional microsatellite markers (D6S265, D6S2222, D6S105 and D6S2239) spanning 5 Megabases in the 6p21.3 region.ResultsEighty-two extended C282Y carrying haplotypes were defined. Single-locus analysis revealed that the HLA-A region was associated with CD8+ T-cell numbers. Multivariate analysis showed that the combinations of the most common HLA-A alleles (HLA-A*03, -A*02 and -A*01) were associated with significantly lower numbers of CD8+ T-lymphocytes (0.30 ± 0.14 × 106/ml), in comparison with subjects carrying only one copy of those alleles (0.46 ± 0.19 × 106/ml) and subjects without any copy of those alleles (0.79 ± 0.15 × 106/ml;p = 0.0001). No differences were observed in CD8+ T-cell counts among control subjects carrying the same combinations of HLA-A alleles (0.47 ± 0.14; 0.45 ± 0.21 and 0.41 ± 0.17 × 106/ml, respectively), therefore not supporting a direct effect of HLA specificity but rather an indirect association with a locus close to HLA-A. Multivariate analysis showed that the combination of the most common HLA-A alleles also have an impact on the clinical expression of HH in terms of iron stores, in males(p = 0.0009).ConclusionThe present study provides evidence supporting an inextricable link between extended HLA haplotypes, CD8+ T-lymphocyte numbers and severity of iron overload in hereditary hemochromatosis(HH). It gives additional information to better define a candidate region involved in the regulation of CD8+ T-lymphocyte numbers. A new evolutionary hypothesis concerning the inheritance of the phenotype of low CD8+ T-lymphocyte numbers associated with particular ancestral HLA haplotypes carrying the C282Y mutation and its implication on the clinical heterogeneity of HH is discussed.
Human Immunology | 2001
Carla Cardoso; Graça Porto; Rosa Lacerda; Dolores Resende; Pedro Rodrigues; Fernanda Bravo; José Carlos Oliveira; Benvindo Justiça; Maria de Sousa
Low CD8(+) T lymphocyte numbers have contributed to deciphering the genotype/phenotype discrepancies found in hereditary hemochromatosis (HH) patients genotyped for the Hfe mutations, C282Y and H63D. In this study, we extend the analysis of T lymphocytes in HH to the T cell receptor (TcR) repertoire. Thirty-two HH patients (C282Y homozygous) and 274 Hfe genotyped healthy subjects were studied. The following TcR chains were analyzed: Valpha2.3, Vbeta5.1, Vbeta5.2, Vbeta5.3, Vbeta6.7, Vbeta8, and Vbeta12 among the CD4(+) and CD8(+) populations. Lymphopenias and absence of expansions of the Vbeta5.2 and Vbeta12 chains in the CD8(+) pool were seen in controls heterozygous for the C282Y mutation. Expansions in the control group were seen within the CD8(+) pool and were rare/absent within the CD4(+) pool. TcR expansions were found more frequent in patients with iron overload related pathology than in patients without pathology. 9/16 of the patients with pathology have at least one expansion among the CD8(+) pool a number significantly higher compared with patients without pathology (1/16). These findings suggest that Hfe has an effect in the shaping of T-cell populations either directly, as indicated by the lymphopenia seen in the two chains in C282Y heterozygous without iron overload, or indirectly by contributing to iron overload pathology.
BMC Medical Genetics | 2008
Eugénia Cruz; Chris Whittington; Samuel H Krikler; Cláudia Mascarenhas; Rosa Lacerda; Jorge Vieira; Graça Porto
BackgroundHereditary Hemochromatosis(HH) is a common genetic disorder of iron overload where the large majority of patients are homozygous for one ancestral mutation in the HFE gene. In spite of this remarkable genetic homogeneity, the condition is clinically heterogeneous, varying from a severe disease to an asymptomatic phenotype with only abnormal biochemical parameters. The recent recognition of the variable penetrance of the HH mutation in different large population studies demands the need to search for new modifiers of its phenotypic expression. The present study follows previous observations that MHC class-I linked genetic markers, associated with the setting of CD8+ T-lymphocyte numbers, could be clinically relevant modifiers of the phenotypic expression in HH, and aimed to find new markers that could be used as more reliable prognostic variables.MethodsHaplotype analysis, including seven genetic markers within a 1 Mb region around the microsatellite D6S105 was performed in a group of 56 previously characterized C282Y homozygous Portuguese patients. Parameters analyzed in this study were total body iron stores, clinical manifestations related with HH and immunological parameters (total lymphocyte numbers, CD4+ and CD8+ T-lymphocyte numbers). An independent group of 10 C282Y homozygous patients from Vancouver, Canada, were also included in this study and analyzed for the same parameters.ResultsA highly conserved ancestral haplotype defined by the SNP markers PGBD1-A, ZNF193-A, ZNF165-T (designated as A-A-T) was found associated with both abnormally low CD8+ T-lymphocyte numbers and the development of a severe clinical expression of HH. In a small proportion of patients, another conserved haplotype defined by the SNP markers PGBD1-G, ZNF193-G, ZNF165-G (designated as G-G-G) was found associated with high CD8+ T-lymphocyte numbers and a milder clinical expression. Remarkably, the two conserved haplotypes defined in Portuguese patients were also observed in the geographically different population of Canadian patients, also predicting CD8+ T-lymphocyte numbers and the severity of disease.ConclusionThese results may have important implications not only for approaching the question of the penetrance of the hemochromatosis gene in different world populations but also to further narrow the region of interest to find a candidate gene involved in the setting of CD8+ T-lymphocyte numbers in humans.
International Journal of Immunogenetics | 2007
Jorge Vieira; Carla Cardoso; J.P. Pinto; Kaustubh Patil; Pavel Brazdil; Eugénia Cruz; Cláudia Mascarenhas; Rosa Lacerda; A. Gartner; Susana Almeida; Helena Alves; Graça Porto
Significant associations between human leucocyte antigen (HLA)‐A and ‐B alleles and CD8+ T‐lymphocyte numbers have been reported in the literature in both healthy populations and in HFE‐haemochromatosis patients. In order to address whether HLA alleles themselves or alleles at linked genes are responsible for these associations, several genetic markers at the MHC class I region were typed on a population of 147 apparently healthy unrelated subjects phenotypically characterized for their CD8+ and CD4+ T‐lymphocyte numbers. By using a machine learning approach, a set of rules was generated that predict the number of CD8+ T‐lymphocyte numbers on the basis of the information of the D6S105 microsatellite alleles only. We demonstrate that the previously reported associations with HLA‐A and ‐B alleles are due to the presence of common long (up to 4 megabases long) haplotypes that increased in frequency recently due to positive selection and that encompass a region where a putative gene contributing to the setting of CD8+ T lymphocytes is located, in the neighbourhood of microsatellite locus D6S105, in the 6p21.3 region.
Clinical Endocrinology | 2004
Graça Porto; Eugénia Cruz; Helena Pessegueiro Miranda; Beatriz Porto; José Carlos Vasconcelos; Rosa Lacerda; Antonella Roetto; Filomena Daraio; Conceição Bacelar
This paper describes a rare case of Turners syndrome associated with Juvenile Haemochromatosis and severe lymphopenia, followed‐up for a period of 5 years. Because of the indication for treatment with growth hormone (GH), this case was observed as a model to analyse the effects of GH on growth, iron mobilization and lymphocyte reconstitution. For this purpose, a serial study of the T lymphocyte subpopulations CD4+, CD8+, CD8+ CD28+ and CD8+ CD28‐ was performed by immunophenotyping during the follow‐up period. Besides the impact of both phlebotomy treatment and GH on the rapid growth and mobilization of 20·8 g of iron in 136 weeks, the most relevant observation was the finding of a significant expansion of CD8+ T lymphocytes expressing the costimulatory marker CD28 in the setting of the severe lymphopenia. These findings constitute new clinical evidence supporting the notion that the GH/IGF‐1 system has an important role on the maintenance of T cell homeostasis in vivo, and that GH may be regarded as a putative therapeutic agent in T lymphocyte reconstitution.
Hepatology | 1997
Graça Porto; Corália Vicente; M A Teixeira; O Martins; José Manuel Cabeda; Rosa Lacerda; Cristina Gonçalves; José Fraga; Guilherme Macedo; Branca M. Silva; Helena Alves; Benvindo Justiça; M de Sousa
Blood Cells Molecules and Diseases | 1999
Lúcia Lacerda; Fernando A. Arosa; Rosa Lacerda; José Manuel Cabeda; Graça Porto; Olga Amaral; Ana Fortuna; Rui Pinto; Pedro Oliveira; Christine E. McLaren; Clara Sá Miranda; Maria de Sousa
Blood Cells Molecules and Diseases | 2006
Eugénia Cruz; Graça Melo; Rosa Lacerda; Susana Almeida; Graça Porto
Tissue Antigens | 2004
Eugénia Cruz; J. Vieira; Ricardo Gonçalves; Helena Alves; Susana Almeida; Pedro Rodrigues; Rosa Lacerda; Graça Porto